Letters From trial to practice

Authors’ reply

BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c5826 (Published 19 October 2010) Cite this as: BMJ 2010;341:c5826
  1. Paul Glasziou, professor for the Weston Manor Group1
  2. On behalf of Iain Chalmers, Douglas G Altman, Hilda Bastian, Isabelle Boutron, Anne Brice, Gro Jamtvedt, Andrew Farmer, Davina Ghersi, Trish Groves, Carl Heneghan, Sophie Hill, Simon Lewin, Susan Michie, Rafael Perera, Valerie Pomeroy, Julie Tilson, Sasha Shepperd, and John W Williams.
  1. 1Bond University, Gold Coast, Australia, and Department of Public Health and Primary Care, University of Oxford, Oxford OX3 7LF, UK
  1. Paul_Glasziou{at}bond.edu.au

We are delighted that Lenz and his colleagues are planning a database of complex interventions.1 However, the problem of taking treatments from idea to practice addressed by our paper2 is not confined to complex interventions: a recent review of chemotherapy found missing details in 89% of recent oncology trial publications.3 Hence we aimed to develop a conceptual model of the …

View Full Text

Log in

Log in through your institution


* For online subscription